Dr Arianne Baldomero Discusses Rural Health Care of Veterans With COPD
October 19th 2022Arianne Baldomero, MD, MS, a pulmonologist in the Veterans Health Administration, discusses findings of a study looking at chronic obstructive pulmonary disease (COPD) disease management for veterans in rural areas.
Read More
Dr Emily Brigham on the Burden of Climate Change and Urban Lung Health
October 19th 2022Urban areas face a concentration of various pollutants that will be exacerbated by the increasing temperatures caused by climate change, and low-income residents likely have fewer resources to withstand negative health impacts, according to Emily Brigham, MD, MHS, of the University of British Columbia.
Read More
Patients on Biologics for Severe Asthma Show Reduced Response to SARS-CoV-2 Vaccination
October 18th 2022Martin Runnström, MD, a fourth-year fellow at the Emory University School of Medicine, describes a study he presented at CHEST 2022 showing a reduced response to a 2-dose immunization series for SARS-CoV-2 among patients using biologics to treat severe asthma or atopic dermatitis.
Read More
Returning to a Humanistic Approach of Preventing Delirium in the ICU
October 18th 2022In the Roger C. Bone Memorial Lecture in Critical Care at CHEST 2022, E. Wesley Ely, MD, MPH, of the Vanderbilt University School of Medicine, highlights the need for humanism in the intensive care unit and how the COVID-19 pandemic destroyed what had been built up.
Read More
Dr Basil Kahwash on the Comorbidity With the Greatest Impact on Asthma Outcomes
October 17th 2022Some atopic diseases affect asthma outcomes more than others, said Basil Kahwash, MD, an assistant professor of medicine on the clinical educator track in the Department of Medicine at Vanderbilt University Medical Center, who spoke at CHEST 2022.
Read More
Pulmonary Embolism Treatments Are Evolving, Says Dr Parth Rali
October 16th 2022There are several closely watched randomized trials examining catheter-directed therapies for acute pulmonary embolism, according to Parth Rali, MD, an associate professor of thoracic medicine and surgery at the Lewis Katz School of Medicine and director of the Temple University Health System Pulmonary Embolism Response Team.
Read More
Patients With Uncontrolled Asthma May Need to Be Considered for Triple Therapy, Posters Find
October 16th 2022One poster found patients with uncontrolled asthma had improved outcomes after escalating to triple therapy, while the other found a substantial portion of patients adherent to a dual therapy reported not having controlled asthma.
Read More
Dr Kara Dupuy-McCauley Discusses Obesity and Response to Viruses, Vaccines
October 16th 2022While more research is needed, obesity does play a role in the response to viral infections as well as immunizations, said Kara Dupuy-McCauley, MD, a pulmonologist at the Mayo Clinic in Rochester, Minnesota.
Read More
Addressing Disparities Starts With Rebuilding Trust, Connecting Better With Patients
October 16th 2022The first 5 minutes of a patient’s visit with a doctor can help improve communication and build more trusting relationships, explained panelists during a session on lung health disparities in America at CHEST 2022.
Read More
Climate Change, Health Disparities Take the Stage at CHEST 2022
October 12th 2022As with many medical meetings, some of the presentations from the annual American College of Chest Physicians event will be livestreamed or on demand for later viewing, but the organizers have stressed the importance of coming together for the first time since 2019.
Read More
Dr Subani Chandra on the Value of In-Person Connections During CHEST 2022
October 11th 2022CHEST 2022 is being held in Nashville, Tennessee, beginning October 16, and Subani Chandra, MD, FCCP, the chair of the Scientific Program Committee, discusses why meeting in real life as opposed to virtually is energizing, even if medical conferences are hectic.
Read More
Additional Data on Possible Chronic Cough Therapy Presented at CHEST 2021
October 20th 2021There are currently no FDA-approved treatments for refractory chronic cough or unexplained chronic cough. At the CHEST Annual Meeting 2021, attendees heard a readout from a durability study as well as pooled analyses from 2 phase 3 trials for gefapixant.
Read More
Dr Evan Stepp: Patient Concern Over EVALI Appears to Have Faded
October 20th 2021Evan L. Stepp, MD, FCCP, CPE, a pulmonologist at National Jewish Health, discusses an apparent change in attitudes among patients in the wake of 2019’s e-cigarette or vaping use–associated lung injury (EVALI) crisis.
Read More
Effects of Type 2 Inflammation in Allergic Disease: Visible, Invisible, Complex
October 20th 2021There has been a huge shift forward in the understanding of innate and adaptive immune mechanisms that provoke type 2 inflammation in atopic disease and eosinophilic esophagitis, according to a CHEST Annual Meeting 2021 speaker.
Read More
Dr Malvika Kaul: Paradoxical Bronchospasm Should Be More Recognized in COPD, Asthma
October 19th 2021Paradoxical bronchospasm, although rare, should be recognized more often in spirometry tests, said pulmonologist Malvika Kaul, MD, who discussed study findings from a population of veterans with chronic obstructive pulmonary disease (COPD) and asthma, where the possibly life-threatening condition was not picked up in lung tests.
Read More
Dr Nicole Herbst on the Effect of ICU Visitor Restrictions on Provider Burnout
October 19th 2021Nicole Herbst, MD, a pulmonary and critical care fellow, talks about how visitor restrictions and communication practices in intensive care units (ICUs) during the COVID-19 pandemic negatively impacted provider job satisfaction and were linked to job burnout, according to a survey presented at the CHEST Annual Meeting 2021.
Read More
Addressing Disparities in Uptake, Screening, and Research for Lung Cancer Care
October 19th 2021A panel discussion at the CHEST Annual Meeting 2021 discussed disparities related to race, ethnicity, gender, and socioeconomic status that have been shown to impact access to high-quality lung cancer care.
Read More
Dr Don Sin on the Barriers to Precision Medicine for COPD
October 18th 2021There are several reasons as to why precision therapeutics have not taken off for chronic obstructive pulmonary disease (COPD) in the same way that they have for other diseases, said Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital.
Read More
Dr Evan Stepp on the FDA’s Decision to Authorize an e-Cigarette
October 17th 2021Evan L. Stepp, MD, FCCP, CPE, a pulmonologist at National Jewish Health, director of the Highlands Ranch Clinic, and an assistant professor, Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, discussed the recent FDA decision to authorize an e-cigarette intended to help current smokers quit combustible cigarettes.
Read More
For CHEST 2021 and Beyond, Expect to Hear More About Cannabis, COVID-19, Chronic Lung Disease
October 13th 2021Don Sin, MD, FRCP, MPH, who is presenting at CHEST 2021 on the topic of precision medicine and chronic obstructive pulmonary disease, discusses other topics of interest at CHEST 2021, which takes place virtually from October 17 to October 20, 2021.
Read More
COVID-19 Topics and More Featured at CHEST 2021
October 13th 2021Compared with conferences held a year ago at this time, when vaccines were not yet available and the United States had yet to hit the peak of the pandemic, there are now more data to discuss about what we know and do not know about COVID-19.
Read More